SAN DIEGO, April 20, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced it will showcase
the Company's new RELINE® Trauma portfolio and O.R. virtual reality
(VR) simulation at the American Association of Neurological
Surgeons (AANS) Annual Scientific Meeting held April 22-26, 2017 in Los Angeles.
Launched earlier this week, RELINE Trauma will help define the
standard of spine trauma care by providing surgeons the flexibility
to customize their approach intra-operatively, including
traditional open, MAS® (Maximum Access Surgery) or hybrid
procedures, depending on the pathology and patient needs.
Seamlessly integrated with the Company's Integrated Global
Alignment® (iGA) platform, RELINE Trauma allows for controlled
fracture correction throughout the procedure, with or without a rod
present in the construct.
"RELINE Trauma is the most versatile trauma system on the
market," said Jason Hannon,
NuVasive's president and chief operating officer. "In collaboration
with our surgeon partners, we've succeeded in creating a platform
designed not only to improve clinical outcomes, but also to reduce
the total cost of care."
Additionally, NuVasive will showcase an immersive VR experience
designed to familiarize surgeons with the techniques of the RELINE
Trauma system. The VR simulation provides step-by-step instruction
of the procedure, while helping develop the associated muscle
memory required to address a burst fracture in an interactive O.R.
setting.
NuVasive 2017 AANS Annual Scientific Meeting Participation
Details
NuVasive will showcase its market-leading,
procedurally-integrated technologies, including the new RELINE
Trauma system and VR experience at NuVasive Booth #1327 on
the AANS Annual Scientific Meeting exhibit floor.
The Company also will host a lunch and learn workshop presented
by Regis Haid, M.D., Christopher Shaffrey, M.D., and Juan Uribe, M.D., titled "Advanced Techniques in
Achieving Integrated Spinal Alignment" on April 24, 2017 from 1:10
p.m. to 1:55 p.m. in room 309.
Visit here for more details and schedule of events.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is a world leader in minimally invasive,
procedurally-integrated spine solutions. From complex spinal
deformity to degenerative spinal conditions, NuVasive is
transforming spine surgery with innovative technologies designed to
deliver reproducible and clinically proven surgical outcomes.
NuVasive's highly differentiated, procedurally-integrated solutions
include access instruments, implantable hardware and software
systems for surgical planning and reconciliation technology that
centers on achieving the global alignment of the spine. With
$962 million in revenues (2016),
NuVasive has an approximate 2,300 person workforce in more than 40
countries around the world. For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons,
development and acceptance of new products or product enhancements,
clinical and statistical verification of the benefits achieved via
the use of NuVasive's products (including the iGA®platform),
the Company's ability to effectually manage inventory as it
continues to release new products, its ability to recruit and
retain management and key personnel, and the other risks and
uncertainties described in NuVasive's news releases and
periodic filings with the Securities and Exchange
Commission. NuVasive's public filings with the Securities
and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-unveils-new-trauma-portfolio-and-virtual-reality-simulation-at-aans-2017-300443022.html
SOURCE NuVasive, Inc.